Review: taking Lexapro and Abilify together


Summary

Drug interactions are reported among people who take Lexapro and Abilify together. This review analyzes the effectiveness and drug interactions between Lexapro and Abilify. It is created by eHealthMe based on reports of 2,282 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lexapro and Abilify >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lexapro

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. (latest outcomes from Lexapro 44,435 users)

Abilify

Abilify has active ingredients of aripiprazole. It is often used in bipolar disorder. (latest outcomes from Abilify 35,575 users)

On Aug, 29, 2016

2,282 people who take Lexapro, Abilify are studied.


Number of reports submitted per year:

Lexapro and Abilify drug interactions.

Drug effectiveness over time:

Lexapro:
  • < 1 month: 14.0% - (1 of 7 people)
  • 1 - 6 months: 24.0% - (6 of 25 people)
  • 6 - 12 months: 31.0% - (5 of 16 people)
  • 1 - 2 years: 17.0% - (4 of 23 people)
  • 2 - 5 years: 37.0% - (16 of 43 people)
  • 5 - 10 years: 40.0% - (4 of 10 people)
  • 10+ years: 42.0% - (3 of 7 people)
  • not specified: 50.0% - (1 of 2 people)
Abilify:
  • < 1 month: 16.0% - (4 of 24 people)
  • 1 - 6 months: 30.0% - (12 of 39 people)
  • 6 - 12 months: 41.0% - (5 of 12 people)
  • 1 - 2 years: 17.0% - (3 of 17 people)
  • 2 - 5 years: 36.0% - (7 of 19 people)
  • 5 - 10 years: 71.0% - (5 of 7 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 66.0% - (2 of 3 people)

Drug effectiveness by gender:

Lexapro:
  • female: 34.0% - (27 of 78 people)
  • male: 23.0% - (13 of 55 people)
Abilify:
  • female: 30.0% - (22 of 73 people)
  • male: 32.0% - (16 of 49 people)

Drug effectiveness by age:

Lexapro:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 21.0% - (4 of 19 people)
  • 20-29: 30.0% - (7 of 23 people)
  • 30-39: 36.0% - (12 of 33 people)
  • 40-49: 25.0% - (7 of 27 people)
  • 50-59: 30.0% - (7 of 23 people)
  • 60+: 37.0% - (3 of 8 people)
Abilify:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 11.0% - (2 of 17 people)
  • 20-29: 31.0% - (7 of 22 people)
  • 30-39: 31.0% - (10 of 32 people)
  • 40-49: 45.0% - (10 of 22 people)
  • 50-59: 28.0% - (6 of 21 people)
  • 60+: 37.0% - (3 of 8 people)

Most common drug interactions over time *:

< 1 month:
  • suicide attempt
  • intentional overdose
  • depression
  • anxiety
  • dizziness
  • somnolence
  • fatigue
  • overdose
  • suicidal ideation
  • tremor
1 - 6 months:
  • depression
  • type 2 diabetes mellitus
  • suicidal ideation
  • anxiety
  • headache
  • diabetes mellitus
  • suicide attempt
  • hallucination
  • overdose
  • blood cholesterol increased
6 - 12 months:
  • type 2 diabetes mellitus
  • weight increased
  • tremor
  • diabetic neuropathy
  • confusional state
  • depression
  • diabetes mellitus
  • dyskinesia
  • diabetes mellitus inadequate control
  • dysarthria
1 - 2 years:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • blood cholesterol increased
  • chest pain
  • sleep apnoea syndrome
  • tardive dyskinesia
  • weight increased
  • convulsion
  • diabetic neuropathy
2 - 5 years:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • neuropathy peripheral
  • breast pain
  • pancreatitis
  • chest pain
  • suicidal ideation
  • depression
  • hyperglycaemia
  • nipple pain
5 - 10 years:
  • suicidal ideation
  • chest pain
  • dysmenorrhoea
  • dyspnoea
  • menorrhagia
  • pain
  • pulmonary embolism
  • type 2 diabetes mellitus
  • diabetes mellitus
  • neuropathy peripheral
10+ years:
  • depression
  • weight increased
  • diabetes mellitus
  • abdominal pain
  • arthritis
  • back injury
  • blindness
  • breast mass
  • cardiac disorder
  • chest pain
not specified:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • weight increased
  • anxiety
  • suicidal ideation
  • dizziness
  • chest pain
  • nausea
  • blood cholesterol increased

Most common drug interactions by gender *:

female:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • depression
  • weight increased
  • suicidal ideation
  • anxiety
  • obesity
  • dizziness
  • blood cholesterol increased
  • suicide attempt
male:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • weight increased
  • suicidal ideation
  • anxiety
  • tardive dyskinesia
  • chest pain
  • depression
  • convulsion
  • fatigue

Most common drug interactions by age *:

0-1:
  • drug exposure during pregnancy
  • premature baby
  • chorioamnionitis
  • drug exposure via breast milk
  • feeding disorder neonatal
  • intra-uterine death
  • failure to thrive
  • gastrooesophageal reflux disease
  • menstrual disorder
  • apathy
2-9:
  • tic
  • aggression
  • weight increased
  • acne
  • blood cholesterol increased
  • blood triglycerides increased
  • colitis
  • crohn's disease
  • depression
  • dry eye
10-19:
  • suicide attempt
  • suicidal ideation
  • depression
  • hallucination
  • weight increased
  • abnormal behaviour
  • agitation
  • anxiety
  • aggression
  • somnolence
20-29:
  • type 2 diabetes mellitus
  • weight increased
  • overdose
  • diabetes mellitus
  • fatigue
  • convulsion
  • depression
  • vomiting
  • anxiety
  • suicidal ideation
30-39:
  • diabetes mellitus
  • type 2 diabetes mellitus
  • blood cholesterol increased
  • depression
  • obesity
  • weight increased
  • suicidal ideation
  • blood triglycerides increased
  • vomiting
  • diabetes mellitus inadequate control
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • obesity
  • weight increased
  • depression
  • diabetes mellitus inadequate control
  • neuropathy peripheral
  • blood cholesterol increased
  • hypertension
  • anxiety
50-59:
  • diabetes mellitus
  • weight increased
  • type 2 diabetes mellitus
  • depression
  • anxiety
  • blood cholesterol increased
  • diarrhoea
  • nausea
  • dizziness
  • pain
60+:
  • dizziness
  • tardive dyskinesia
  • diabetes mellitus
  • pneumonia
  • haemoglobin decreased
  • headache
  • nervousness
  • restlessness
  • mental impairment
  • feeling abnormal

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lexapro and Abilify?

Can you answer these questions?

More questions for: Lexapro, Abilify

You may be interested in these reviews

More reviews for: Lexapro, Abilify

On eHealthMe, Lexapro (escitalopram oxalate) is often used to treat depression. Abilify (aripiprazole) is often used to treat bipolar disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.